InvestorsHub Logo

X Master

10/24/22 2:33 AM

#524280 RE: HyGro #524277

How would you know what the results are of the current trial with Merck are? Do you think they would say gee the results are excellent and then months later buy the company? Or would you impose a quiet period for months, drive the price down and accumulating shares during the approval process?

The Danish Dude

10/24/22 5:20 AM

#524283 RE: HyGro #524277

Truth will out. So far all of this is true -- Merck has shown no interest.



Your DD is second to none :-d

No interest huh?

That's why Merck got UCLA to throw out Bristol Meyers Squibb from the SPORE 1 project in 2019 and replace Opdivo (nivolumab) with Keytruda (pembrolizumab), which is now the combo trial. A combo trial where Merck is sponsoring Keytruda FOR FREE, which big pharma usually DON'T DO.

I love your due diligence. It gives me some of the most humoristic moments every week.

Oh ... that is the cue for you claiming, that ATL-DC is not DCvax-L. That Linda Liau has distanced herself from NWBO (which is why she will talk about DCVax-L 3 times the next month) and she is making her "own version".

Oh I'm giggling myself to death now :-d

Horseb4CarT

10/24/22 5:33 AM

#524284 RE: HyGro #524277

Truth! You can’t handle the truth!

Hooyaaahhhh!!!

Dr Bala

10/24/22 7:05 AM

#524304 RE: HyGro #524277

I was talking about the nonsensical speculations in the last paragraph.